Insulin Antilipolytic (Prevents Fat Loss)

  1. Antilipolyticย effect ofย insulinย in isolated fat cells of the rat
  2. Theย Antilipolyticย action ofย insulinย in obese subjects with resistance to its glucoregulatory action
  3. Effect of cell size on lipolysis andย Antilipolyticย action ofย insulinย in human fat cells
  4. Antilipolyticย action ofย insulinย on fat cells
  5. Systemic resistance to theย Antilipolyticย effect ofย insulinย in black and white women with visceral obesity
  6. Various phosphodiesterase subtypes mediate the in vivoย Antilipolyticย effect ofย insulinย on adipose tissue and skeletal muscle in man
  7. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and theย Antilipolyticย action ofย insulinย in isolated rat adipocytes
  8. Antilipolyticย action ofย insulin: role of cAMP phosphodiesterase activation
  9. Theย Antilipolyticย effect ofย insulinย in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation
  10. Adipose tissue lipolysis revisited (again!): lactate involvement inย insulinย Antilipolyticย action
  11. Insensitivity of large rat adipocytes to theย Antilipolyticย effects ofย insulin
  12. Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in theย Antilipolyticย action ofย insulin
  13. Pro12Ala Polymorphism in the Peroxisome Proliferatorโ€“Activated Receptor-ฮณ2 Gene Is Associated With Increasedย Antilipolyticย insulinย Sensitivity
  14. insulinย receptor down-regulation and impairedย Antilipolyticย action ofย insulinย in diabetic patients after pancreas/kidney transplantation
  15. Antilipolyticย actions of vanadate andย insulinย in rat adipocytes mediated by distinctly different mechanisms
  16. A longitudinal study of theย Antilipolyticย effect ofย insulinย in women following bariatric surgery
  17. Antilipolyticย effects ofย insulinย and adenylate cyclase inhibitors on isolated human fat cells.
  18. Effect of theย Antilipolyticย nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes โ€ฆ
  19. Regulation ofย insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic andย Antilipolyticย agents.
  20. Role of phosphodiesterase III in theย Antilipolyticย effect ofย insulinย in vivo
  21. Influence of obesity on theย Antilipolyticย effect ofย insulinย in isolated human fat cells obtained before and after glucose ingestion.
  22. insulin-mimetic compound hexaquis (benzylammonium) decavanadate isย Antilipolyticย in human fat cells
  23. Glucocorticoids antagonize tumor necrosis factor-ฮฑ-stimulated lipolysis and resistance to theย Antilipolyticย effect ofย insulinย in human adipocytes
  24. Evidence for marked sensitivity to theย Antilipolyticย action ofย insulinย in obese maturity-onset diabetics
  25. Theย Antilipolyticย effects ofย insulinย and epidermal growth factor in rat adipocytes are mediated by different mechanisms
  26. Molecular mechanisms involved in theย Antilipolyticย action ofย insulin: phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase
  27. Antilipolyticย actions ofย insulinย on basal and hormone-induced lipolysis in rat adipocytes
  28. Overactivation of the endocannabinoid system alters theย Antilipolyticย action ofย insulinย in mouse adipose tissue
  29. Comparative studies of theย Antilipolyticย effect ofย insulinย and adenosine in the perifused isolated fat cell
  30. Theย Antilipolyticย effect ofย insulinย in human adipocytes requires activation of the phosphodiesterase
  31. Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory norย Antilipolyticย effect ofย insulinย in type 2 (non-insulin-dependent) diabetic patients
  32. Glucose stimulation of theย Antilipolyticย effect ofย insulinย in humans
  33. Resistance to theย Antilipolyticย effect ofย insulinย in adipocytes of African-American compared to Caucasian postmenopausal women
  34. PKB inhibition prevents the stimulatory effect ofย insulinย on glucose transport and protein translocation but not theย Antilipolyticย effect in rat adipocytes
  35. Upstream transcription factor 1 gene polymorphisms are associated with highย Antilipolyticย insulinย sensitivity and show geneโ€“gene interactions
  36. Mediation of theย Antilipolyticย and lipogenic effects ofย insulinย in adipocytes by intracellular accumulation of hydrogen peroxide
  37. Studies on the sites of theย Antilipolyticย action ofย insulinย in adipose tissue
  38. Islet-activating protein discriminates theย Antilipolyticย mechanism ofย insulinย from that of otherย Antilipolyticย compounds
  39. Genistein, a plant-derived isoflavone, counteracts theย Antilipolyticย action ofย insulinย in isolated rat adipocytes
  40. insulin-like action of ouabain II. Primaryย Antilipolyticย effect through inhibition of adenyl cyclase
  41. Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory orย Antilipolyticย effect ofย insulinย in nondiabetic subjects with mild hypertriglyceridemia
  42. Theย Antilipolyticย effect ofย insulinย does not require adenylate cyclase or phosphodiesterase action
  43. Cell size and theย Antilipolyticย effect ofย insulinย in human subcutaneous adipose tissue
  44. Antilipolyticย action ofย insulinย in adipocytes from starved and diabetic rats during adenosine-controlled incubations
  45. The effect of anย Antilipolyticย agent (acipimox) on theย insulinย resistance of lipid and glucose metabolism in hypertriglyceridaemic patients
  46. Evidence for Separate Sites of Action for theย Antilipolyticย Effects ofย insulinย and Prostaglandin E1
  47. Comparisons of the Effects of Bacillus subtilis Protease, Type VIII (Subtilopeptidase A), andย insulinย on Isolated Adipose Cells: II.ย Antilipolyticย ACTION
  48. Preservedย Antilipolyticย insulinย action is associated with a less atherogenic plasma lipid profile in healthy centenarians
  49. Theย Antilipolytic,ย insulin-like effect of growth hormone is caused by a net decrease of hormone-sensitive lipase phosphorylation
  50. A novel index of whole bodyย Antilipolyticย insulinย action
  51. Effect of p-chlorophenoxyisobutyrate on theย Antilipolyticย action ofย insulinย andย insulinย binding in isolated adipocytes
  52. Antilipolyticย action ofย insulinย in the perifused fat cell system
  53. PID1 alters theย Antilipolyticย action ofย insulinย and increases lipolysis via inhibition of AKT/PKA pathway activation
  54. The glucoregulatory andย Antilipolyticย actions ofย insulinย in abdominal obesity with normal or impaired glucose tolerance: an in vivo and in vitro study
  55. SUCROSE FEEDING IN MAN: Effects on Lipolysis andย Antilipolyticย Action ofย insulinย in the Adipose Tissue
  56. Lipolysis and theย Antilipolyticย effect ofย insulinย in adipocytes from rats adapted to a high-protein diet
  57. insulin-like,ย Antilipolyticย actions of phospholipase A in isolated rat adipose cells
  58. Comparison of the responsiveness of perirenal adipose tissue of the rat, hamster, guinea pig and rabbit to theย Antilipolyticย action ofย insulin
  59. Mechanism of action ofย Antilipolyticย agents: comparison of the effects ofย insulin, tolbutamide, and phenformin on lipolysis induced by dibutyryl cyclic AMP plus โ€ฆ
  60. A growth hormone (GH) analog that antagonizes the lipolytic effect but retains fullย insulin-like (Antilipolytic) activity of GH
  61. Antilipolyticย effect ofย insulinย andย insulinย receptor messenger RNA expression in adipocytes of infants, children, and adults
  62. Decreasedย insulinย binding andย Antilipolyticย response in adipocytes from patients with Cushingโ€™s syndrome
  63. Theย Antilipolyticย Action ofย insulinย on Adrenocorticotrophinโ€Stimulated Rat Adipocytes: The Roles of Adenosine 3โ€ฒ, 5โ€ฒโ€Monophosphate and the Protein Kinase โ€ฆ
  64. Binding andย Antilipolyticย action ofย insulinย in isolated adipocytes from cortisol-treated rats.
  65. Coupling of adenylate cyclase to lipolysis in permeabilized adipocytes: direct evidence that anย Antilipolyticย effect ofย insulinย is independent of adenylate cyclase
  66. Influence of fasting and refeeding on theย Antilipolyticย effect ofย insulinย in human fat cells obtained from obese subjects
  67. Theย Antilipolyticย agent 3, 5-dimethylpyrazole inhibitsย insulinย release in response to both nutrient secretagogues and cyclic adenosine monophosphate agonists in โ€ฆ
  68. Effects of different phosphodiesterase inhibitors on theย Antilipolyticย action ofย insulinย in human adipocytes
  69. Effect of long-term nickel ingestion onย insulinย binding andย Antilipolyticย response in rat adipocytes
  70. Antilipolyticย action ofย insulinย in abdominal adipocytes of obese subjects before and during energy restriction. Influence of adenosine deaminase.
  71. Inhibition by cholera toxin of theย Antilipolyticย action of prostanoids, N6-(phenylisopropyl) adenosine andย insulin
  72. Pertussis toxin reversal of theย Antilipolyticย action ofย insulinย in rat adipocytes in the presence of forskolin does not involve cyclic AMP
  73. Wortmannin convertsย insulinย but not oxytocin from anย Antilipolyticย to a lipolytic agent in the presence of forskolin
  74. Phorbol 12-myristate 13-acetate inhibits theย Antilipolyticย action ofย insulin, probably via the activity of protein kinase Cฮต
  75. A comparison of theย Antilipolyticย effects of nicotinic acid, methylisoxazole carboxylic acid, methylpyrazole carboxylic acid andย insulinย in isolated fat cells
  76. Antilipolyticย Effect ofย insulinย in Nonโ€insulinโ€dependent Diabetes Mellitus after Conventional Treatment with Diet and Sulfonylurea
  77. The Pro12Ala polymorphism in the peroxisome proliferator activated receptor [gamma] 2 gene is associated with increasedย Antilipolyticย insulinย sensitivity in lean โ€ฆ
  78. Evaluation of the effects of forskolin and theย Antilipolyticย agentsย insulinย and nicotinic acid on cyclic AMP levels in rat epididymal adipocytes.
  79. insulin-Like,ย Antilipolyticย Effect of 12-O-Tetradecanoyl Phorbol 13-Acetate in Rat White Adipocytes
  80. Effect of experimentally-induced chronic hyperprolactinemia onย insulinย binding andย Antilipolyticย response in adipocytes from male rats.
  81. Effect of SC-19220, a prostaglandin inhibitor on theย Antilipolyticย action of prostaglandin E2, propranalol andย insulinย in the isolated rat adipocyte
  82. 1222-P: Adipose Tissueย Antilipolyticย insulinย Sensitivity Protects against Whole-Bodyย insulinย Resistance and Lowers Acylcarnitine Accumulation in Adults with Obesity
  83. Investigations on theย Antilipolyticย Activity of Sulfonylureas in Man with Indications on Limit Dosages Concerning theirย insulin-Secreting Properties
  84. Variability in Sensitivity to theย Antilipolyticย Effect ofย insulinย in Adipocytes from Obese Nondiabetic Premenopausal Women
  85. Theย Antilipolyticย effect ofย insulinย and epidermal growth factor in rat adipocytes are mediated by different mechanisms
  86. Temperature and benzyl alcohol as probes of theย Antilipolyticย mechanism ofย insulinย action in adipocytes
  87. Decreasedย Antilipolyticย effect ofย insulinย is associated with low glucose oxidation rate and dyslipidemias in familial combined hyperlipidemia
  88. 230-OR: Exercise Training Improvedย Antilipolyticย Sensitivity toย insulinย in Obese Adults with Low Sensitivity toย insulinย before Training
  89. PID1 altersย Antilipolyticย action ofย insulinย and increases lipolysis via Inhibited the activation of AKT/PKA Pathway
  90. โ€ฆ , and carboxyglycylamide with reference to their blood-sugar-decreasing andย Antilipolyticย effect on completely pancreatectomized dogs, chronically treatedย insulin
  91. Correction: PID1 alters theย Antilipolyticย action ofย insulinย and increases lipolysis via inhibition of AKT/PKA pathway activation
  92. Activation of adipose tissue cannabinoid receptors 1 (CB1R) altersย Antilipolyticย action ofย insulinย and increases lipolysis in mice
  93. โ€ฆ blood sugar decreasing andย Antilipolyticย effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated withย insulinย โ€ฆ

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop